Objectives: The Illness Invalidation Inventory (3*I) assesses patients' perception of responses of others that are perceived as denying, lecturing, not supporting, and not acknowledging the condition of the patient. It includes two factors: 'discounting' and 'lack of understanding'. In order to use the 3*I to compare and to pool scores across groups and countries, the questionnaire must have measurement invariance; that is, it should measure identical concepts with the same factor structure across groups. The aim of this study was to examine measurement invariance of the 3*I across rheumatic diseases, gender, and languages.
INTRODUCTION
Invalidation, defined as the perception of cognitive, affective, and behavioural responses of others that are judged to be denying, lecturing, not supporting, and not acknowledging the condition of the patient, [1] is problematic for some patients with rheumatic diseases.
Symptoms of rheumatic diseases such as pain, fatigue, and stiffness are mostly invisible and because of this, people in the social environment of the patient might forget or misjudge the burden and consequences of the illness. [2] When there is no clinical or laboratory evidence to account for the symptoms of the rheumatic illness, such as in fibromyalgia, [3] this can provoke even more serious disbelief and distrust towards the patients. [4] Indeed, patients with fibromyalgia reported that invalidation is a major issue in their lives, adding a burden to the symptoms. [1, 5] Moreover, invalidation could increase the risk of becoming more physically impaired and depressed, [6] thus highlighting the need for attending to invalidation in research and clinical settings. [7] The Illness Invalidation Inventory (3*I) is a self-report questionnaire that assesses patients' invalidation. An initial evaluation suggested internal consistency and concurrent validity of the inventory. [6] To be able to use the 3*I in epidemiological studies, to make comparisons of invalidation across patient groups and countries, and to examine its antecedents and consequences, the questionnaire must measure identical constructs with the same structure across groups. This means that the factor structure, factor loadings, and thresholds should be comparable across groups, [9] which is called measurement invariance.
Thresholds are the points on the unobserved normal distribution where, on average, respondents vary between two different response options. [8] When measurement invariance is absent, groups or subjects respond differently to items, and factor means cannot validly be compared across groups. As yet, it is unclear whether the 3*I shows measurement invariance across rheumatic diseases, gender, and languages. 4 The 3*I assesses invalidation by the spouse, family, medical professionals, work environment, and social services using eight items for each of these five social sources ( Figure 1 ). The structure for each social source comprises two factors; discounting (5 items) and lack of understanding (3 items). Discounting represents active negative social responses including disbelieving, admonishing, dismissing inability to work, not acknowledging symptom fluctuations, and offering unusable advice. Lack of understanding reflects a lack of positive social responses such as not recognising, comprehending, and emotionally supporting the patient or illness. To date, the Dutch version of the 3*I has been validated in patients with rheumatoid arthritis and fibromyalgia, [6] but measurement invariance across rheumatic diseases, gender, and language versions of the 3*I has not been tested. Furthermore, qualitative studies suggest that invalidating experiences of patients with rheumatic diseases are common in many countries. [4, 5, 10, 11] However, the study of invalidation across countries is only legitimately possible after the equivalence of the language versions (other than Dutch) of the 3*I has been established.
The first aim of the current study was to test the factor structure in a large sample of Dutch patients with several rheumatic diseases and to examine measurement invariance between patients with fibromyalgia and patients with other rheumatic diseases and between men and women. The second aim was to examine measurement invariance between different language versions (Dutch, English, French, German, Portuguese, and Spanish).
METHODS

Participants
Participants were 6,057 people with rheumatic diseases from different countries. Inclusion criteria were (1) the self-report of a rheumatic disease, (2) the report that the disease was 5 diagnosed by a medical specialist, general practitioner, or nurse, (3) being 18 years or older, and (4) speaking Dutch, English, French, German, Portuguese, or Spanish. Table 1 shows the characteristics of the participants, who had a mean age of 45.7 years and were mostly female (88%). With the exception of the German respondents, patients with fibromyalgia constituted the largest percentage of respondents (40-76% across different languages). The German version of the questionnaire was completed by patients with a wide range of conditions, particularly systemic lupus erythematosus (29%) and ankylosing spondylitis (25%). Overall, patients with osteoarthritis (8-28%), rheumatoid arthritis (6-20%), and Sjögren's syndrome (4-21%) were well represented in the study.
Procedure
The study was conducted according to the principles of the Declaration of Helsinki [12] and was tested and approved by the Medical Ethical Committee of the University Medical Center Utrecht.
The software program "Netquestionnaires" [13] was used to develop online international questionnaires. An online version was first developed for the Dutch version, which was pretested among a small sample of Dutch patients. After translation, the other language versions were developed uniformly and pre-tested by a small expert group.
Participants were invited via a recruitment notice on websites of patient associations for rheumatic diseases. Patient associations in Dutch, English, French, German, Portuguese, and Spanish language countries were asked to put the recruitment notice on their website. The text of this notice was similar across countries and patient associations. It is unknown whether (some) patient organizations took additional actions to bring the call to the notice of patients.
On the website, participants could choose one of the six language versions of the study. The recruitment notice included information about the aim and content of the study, inclusion 6 criteria, duration of participation (about 20 minutes), and a hyperlink to the online questionnaire. Participants could decide to participate after being informed about the study, and were able to stop at any point if they desired. Of 8,293 participants who began filling out the questionnaire, 6,057 (77%) completed it and provided the data analyzed here. About 80% of drop outs were participants who stopped filling out the questionnaire while responding to the first demographic questions. 
Instruments
The on-line study included items about demographic characteristics and the Illness Invalidation Inventory.
The Illness Invalidation Inventory (3*I) [6] measures invalidation by each of 5 sources (spouse, family, medical professionals, work environment, and social services). It consists of 2 factors: discounting (5 items) and lack of understanding (3 items; see Figure 1 ). Participants indicate on a 5-point scale (1=never, 2=seldom, 3=sometimes, 4=often, 5=very often) how frequently during the past year people within each category responded to them in the described way. A source category that does not apply can be skipped. An initial validation study in Dutch patients demonstrated good reliability and validity of the 3*I. [6] Translation of the 3*I was done by the forward-and-backward translation method. 
Measurement invariance
The first step to determine measurement invariance is to specify the model (adequate structure) of the instrument. [14] With confirmatory factor analyses (CFA) the factor structure of the model is tested for each group. The second step is to check whether the best fitting factor model is adequate and equal across groups. This can be tested first, by comparing the numerical values of the factor loadings across groups, which should be similar (weak 10 invariance); and, second, by comparing whether the thresholds are similar across groups (scalar invariance). [15] For straightforward interpretation of latent variable means and patterns of correlations across groups, both the factor loadings and thresholds should be similar across groups (strong invariance). [16] When weak invariance is not supported, this could mean that one or more of the common factors have different meanings across the population groups [17] or that a subset of the factor loading estimates for a group is biased due to extreme response style. When strong invariance is not supported, differential additive response bias or differential acquiescence response styles might be the problem.
[18]
Statistical analysis
Single and multiple group CFAs were used to test the factorial structure and measurement invariance by means of Mplus 6.11. [19] First, the Dutch data were used to check whether the model displayed in Figure 1 with two factors fits to the data better than a one-factor model. Furthermore, we investigated models were repeated using a maximum likelihood estimator (MLR), again using a correction for non-normality.
In a second step of analyses, measurement invariance across rheumatic diseases was tested in the Dutch data for patients with only fibromyalgia versus patients with one other rheumatic disease (n = 890). The other 548 patients who reported having two or more comorbid rheumatic diseases were excluded from this analysis. Third, measurement invariance across gender was tested in the Dutch data. Fourth, measurement invariance was tested across languages in the international data using a similar procedure.
In each test of measurement invariance, three models were analyzed; Model 1 includes constrained factor loadings, thresholds free (weak invariance), Model 2 includes constrained thresholds, factor loadings free (scalar invariance), and Model 3 includes both constrained factor loadings and thresholds (strong invariance) [21] .
In a last step of analysis, standardized factor loadings, threshold values, and internal consistency (Cronbach's alpha) were examined.
RESULTS
Factor structure of the Illness Invalidation Inventory
For several items of the 3*I, the score distribution across the response categories were skewed. Therefore, one-and two-factor models with continuous factor indicators were compared to a one-and two-factor model where the items were defined as being categorical. Table 2 shows outcomes of the four CFA for the 3*I source 'family' factor structure in the 12 Dutch data. The two-factor model with categorical items provided the better trade-off between model fit and model complexity according to the BIC criterion and it had adequate fit estimates. Analyses for the four other social sources were repeated and the two-factor model with categorical items also showed the best fit for each source (Supplementary file, Table S1 ). This model has been used in subsequent analyses. Table S2 ). Therefore, Model 3a was chosen as the best model indicating measurement invariance across rheumatic diseases. 
Measurement invariance 3*I across rheumatic diseases
Measurement invariance 3*I across gender
Measurement invariance was also tested across gender in the Dutch data. Table 3 shows the fit-estimates for the source 'family'. Model 3b (strong invariance) best fitted the data: it had adequate CFI, TLI and RMSEA values and the lowest BIC value. Model 3b showed also the lowest BIC value among the other sources (Supplementary file, Table S3 ). This supports measurement invariance across gender.
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Measurement invariance 3*I across languages
In the separate English, French, German, Portuguese, and Spanish data sets, CFA was conducted to examine the two-factor structure of the 3*I for each language version of the 3*I as compared to the Dutch factor structure. The two-factor model showed adequate fit estimates for each language version of the 3*I (results are not shown). Because this result confirmed the equivalence of factor structures of the 3*I across languages, it was feasible to study measurement invariance of the 3*I across the languages.
A multiple group model including all data sets was created to compare Models 1c, 2c
and 3c across languages. Fit estimates are shown in Table 3 for the source 'family' of the 3*I.
All Models (1c, 2c, and 3c) showed adequate CFI and TLI estimates. The fit-estimates showed the best fit for model 1c (weak invariance): in general it had the lowest ²-value, RMSEA, and BIC and the largest CFI and TLI. This model 1c (constrained factor loading, thresholds free) indicates that the factor loadings are invariant across languages, but that threshold values are non-invariant across languages.
To illustrate this finding, consider the standard factor loadings obtained with Model 1c
(factor loadings free, Table 4 ). The factor loadings differ barely between language versions of the 3*I. Thus, constraining these factor loadings to be equal resulted in a simpler model (i.e., less parameters have to be estimated) and it yields a better fit (Table 3) . Table 5 Note. Cross-loadings are set to zero in confirmatory factor analyses. The fit of Model 3c could be improved through partial measurement invariance (setting some thresholds "free", but constraining others). To identify non-invariant thresholds, both the Modification Index (MI) for a parameter, which gives the expected drop in the model's Chisquare value if the parameter is freely estimated, and the value of thresholds across languages can be studied. Ideally, one or two items, or one or two languages would be identified explaining non-invariant thresholds. In that case, a solution would be to delete these items, or to deal differently with computation of factors in this language. In our study, the German data seem most different. However, close inspection of the MI and the (5 times 32) threshold values across languages did not show significant MI's or specific threshold patterns.
Therefore, determining the degree of partial measurement invariance was not attainable.
Because the model assuming strong measurement invariance still has a good fit to the data (i.e., most model fit indices are well above the cut-off values) and differences in threshold values probably cancel each other out between the different languages [8, 22] , we concluded that Model 3c applies for all social sources (Supplementary file, Table S4 ). The Cronbach's alpha per language indicated that the internal consistency of the two 3*I factors is good;
between .76 and .95 for the factor 'discounting' and between .78 and .93 for the factor 'lack of understanding'. This provides additional support for using Model 3c.
DISCUSSION
This study investigated the measurement invariance of the 3*I across rheumatic disease, gender, and language version. Our results confirm the validity of a two-factor structure of the 3*I comprising discounting and lack of understanding for each source (spouse, family, medical professionals, work environment, and social services) in patients with rheumatic diseases. Strong measurement invariance (i.e., constrained factor loadings and thresholds) across rheumatic disease (fibromyalgia versus other rheumatic disease) and across gender was established. Strong measurement invariance across the six language versions of the 3*I was also supported by adequate fit estimates and by good internal consistency of the factors for each language. In most cases, the BIC supported strong measurement invariance, but not all estimates showed the best fit for this model. Because most models under investigation had a moderate to high RMSEA (.08-.14) and about equal CFI and TLI fit statistics, our model selection was largely based on BIC. Although the fit of the model with constrained factor loadings and thresholds was not the best across language, measurement invariance of the 3*I for languages was not rejected. Because all models (weak, scalar, and strong invariance)
showed good fit estimates, it is acceptable to conclude that the different language versions of the 3*I are comparable.
This study has some limitations. First, diagnoses were self-reported by patients, and there was no certification by a medical specialist. Second, participants were recruited through the internet, which may have led to a younger sample from a higher social economic class.
However, this is less of a problem for the examination of measurement invariance, because the instrument should be invariant whether patients do or do not have the disease, are young or old, etc. Third, no expert committee was involved in the translation procedure of the 3*I.
The 3*I is the first instrument to quantify invalidation in patients with rheumatic diseases. Results of our study indicate that comparisons between diseases, gender and language version of the 3*I are possible, and are likely to be not affected by different response styles or different interpretations of items. This is an advantage when examining 19 antecedents and consequences of invalidation as well as the effects of treatments targeting invalidation. In clinical practice, the questionnaire can be used to assess invalidation in individual patients, which will help therapists to understand and treat patients' problems. 20 
